Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

RPI-78M begins phase IIb study in adrenomyeloneuropathy

Jan. 31, 2007

Targeting orexin receptors may be useful to treat sleep disorders

Jan. 31, 2007

New agents for schizophrenia and depression disclosed in recent patents

Jan. 31, 2007

Nasalfent begins phase III program in breakthrough cancer pain

Jan. 31, 2007

Recent Allergan and Florida Atlantic University patents divulge novel analgesic agents

Jan. 30, 2007

T-0047 clinical testing resumes

Jan. 30, 2007

Japanese approval for Modiodal in narcolepsy

Jan. 30, 2007

Valeant develops intranasal diazepam for seizure emergencies

Jan. 30, 2007

Michael J. Fox Foundation funds industry development efforts in Parkinson's

Jan. 30, 2007

Antiparkinsonian effects of S-32504 via D2 receptors are not associated with significant dyskinesia

Jan. 29, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...